Acetylcholine (Re)challenge: From Diagnosis to Targeted Therapy

JACC Cardiovasc Interv. 2022 Jan 10;15(1):76-79. doi: 10.1016/j.jcin.2021.11.022.

Authors

Thomas J Ford¹, Philopatir Mikhail²

Affiliations

¹ Department of Cardiology, Gosford Hospital, Central Coast, Australia; Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia; BHF Cardiovascular Research Centre, ICAMS, University of Glasgow, Glasgow, United Kingdom. Electronic address: tom.ford@health.nsw.gov.au.
² Department of Cardiology, Gosford Hospital, Central Coast, Australia; Faculty of Health and Medicine, University of Newcastle, Callaghan, Australia.

PMID: 34991827
DOI: 10.1016/j.jcin.2021.11.022

No abstract available

Keywords: INOCA; acetylcholine; angina; coronary spasm.

Publication types

Editorial
Comment

MeSH terms

Acetylcholine*
Angina Pectoris / diagnosis
Coronary Vasospasm*
Humans
Treatment Outcome

Substances

Acetylcholine